Masimo Corporation Revenue and Competitors

Location

$5M

Total Funding

Estimated Revenue & Valuation

  • Masimo Corporation's estimated annual revenue is currently $1.2B per year.(i)
  • Masimo Corporation's estimated revenue per employee is $289,335
  • Masimo Corporation's total funding is $5M.
  • Masimo Corporation's current valuation is $12.9B. (January 2022)

Employee Data

  • Masimo Corporation has 4182 Employees.(i)
  • Masimo Corporation grew their employee count by 3% last year.

Masimo Corporation's People

NameTitleEmail/Phone
1
Founder, Chairman & CEOReveal Email/Phone
2
Regional VP, Account ExecutiveReveal Email/Phone
3
Sr. VP OEM BusinessReveal Email/Phone
4
Regional VP Sales- SoutheastReveal Email/Phone
5
Area VPReveal Email/Phone
6
Area VPReveal Email/Phone
7
Regional VP SalesReveal Email/Phone
8
Regional VP Sales, US Post-Acute CareReveal Email/Phone
9
Area VPReveal Email/Phone
10
Regional VP SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Masimo Corporation?

Founded in 1989, Masimo Corporation, the innovator of motion and low perfusion tolerant pulse oximetry, is a privately held medical technology company that develops, licenses and markets advanced medical signal processing technologies and products for the non-invasive monitoring of patient vital signs. Masimo Signal Extraction Technology pulse oximetry, Masimo SET®, represents a fundamental departure from conventional pulse oximetry technologies. Over 60 independent published studies have demonstrated that Masimo SET substantially overcomes the limitations of conventional pulse oximeters in accurately measuring arterial blood oxygen saturation levels and pulse rates in the presence of patient movement and low perfusion. To date, Masimo has licensed its Signal Extraction pulse oximetry technology to over 35 international patient monitoring systems providers, which make up over 60% of the world's pulse oximeter shipments. We invite you to learn more about the products, people, and services that have brought us to where we are today.

keywords:N/A

$5M

Total Funding

4182

Number of Employees

$1.2B

Revenue (est)

3%

Employee Growth %

$12.9B

Valuation

N/A

Accelerator

Masimo Corporation News

2022-04-20 - Prior Publication Does Not Always Bar Trade Secret Protection

Masimo Corp. v. True Wearables, Inc., No. 2021-2146, 2022 U.S. App. LEXIS 1923, at *17 (Fed. Cir. Jan. 24, 2022). This seems counter intuitive...

2022-04-13 - Is Masimo Corporation (MASI) Stock a Smart Value?

Masimo Corporation (MASI) stock is down -43.59% over the last 12 months, and the average rating from Wall Street analysts is a Buy.

2022-03-30 - Masimo Announces Certain Preliminary First Quarter 2022 ...

Masimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$597.4M42834%N/A
#2
$1366.2M4831N/AN/A
#3
$5110M49028%$50.8M
#4
$2423.8M53274%N/A
#5
$1464.6M5599-23%$323M